Affiris forms diabetes vaccine collaboration with Christian Doppler laboratory
This article was originally published in Scrip
Executive Summary
Austria's Affiris has formed a partnership with the Christian Doppler laboratory for cardiometabolic immunotherapy to strengthen its research into chronic inflammatory processes which may help develop therapeutic vaccines against type 2 diabetes and cardiovascular diseases.